Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • 10x Genomics, Berry Genomics Partner On NIPT

    Diagnostics World News Brief 10x Genomics and Berry Genomics announced a collaboration today to further develop approaches for next generation noninvasive prenatal testing (NIPT). The parties will collaborate to enable a new service offering for Berry Genomics.

    Jan 8, 2018
  • Mechanism For Resistance To Immunotherapy Treatment Discovered

    Diagnostics World Brief | Dana-Farber researchers say discovery may help identify kidney cancer and melanoma patients that will benefit from checkpoint inhibitor treatment.

    Jan 5, 2018
  • Illumina, KingMed Diagnostics Partner To Develop NGS Technology For Chinese FDA Approval

    Diagnostics World Brief | Illumina and KingMed Diagnostics today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina's next-generation sequencing technology.

    Jan 4, 2018
  • NYT, Bloomberg Say Apple Is Working On Watch EKG, Noninvasive Glucose

    MobiHealth | Citing anonymous sources within Apple, reports in Bloomberg and the New York Times over the past weeks continue to add to the pile of leaks and rumors about two of Apple's currently under-development health devices: a wrist-worn glucose sensor and an EKG built into the Apple Watch.

    Jan 3, 2018
  • Quanterix, Mobidiag, WuXi NextCODE, And More: News From December 2017

    Diagnostics World | December featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Quanterix, Mobidiag, WuXi NextCODE, and more.

    Jan 3, 2018
  • Too Much Screening Has Misled Us About Cancer Risk Factors

    STAT | Widespread screening for "scrutiny-dependent" cancers is misleading doctors and the public about what increases our risk of developing cancer.

    Jan 2, 2018
  • Top 10 Stories Of 2017: Two Pore Guys, The IVD industry Today, And More

    Diagnostics World | As we head into 2018, we at Diagnostics World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2017.

    Dec 27, 2017
  • FDA Approves, CMS Proposes Coverage For Foundation Medicine’s NGS-Based Test

    Diagnostics World | Foundation Medicine’s FoundationOne CDx test recently became the second NGS-based IVD to be approved and covered after overlapping review by the FDA and CMS under the Parallel Review Program, which facilitates earlier access to innovative medical technologies for Medicare beneficiaries.

    Dec 21, 2017
  • Year In Review: 2017 Conferences, Discussions, Awards

    Diagnostics World | A look back at the conferences held by Cambridge Healthtech Institute, covering a wide range of content that focused on delivering insights on the tools, innovations, and breakthroughs that are emerging from the expanding field of diagnostics.

    Dec 19, 2017
  • Gamers Help Researchers Tackle The Problem Of Protein Folding

    Diagnostics World | Foldit is an online puzzle video game designed to fold the structures of selected proteins as perfectly as possible. Recently, the developers of the game have been partnering with companies and institutions, including Mars Incorporated and Thermo Fisher Scientific, to help target the issue of carcinogens in food.

    Dec 13, 2017
  • Advances In Lateral Flow Technology: Addressing The Limitations Of Traditional Conjugate Blocking

    Diagnostics World Contributed Commentary | Lateral flow immunoassays are simple yet powerful diagnostic tools, offering user-friendly, reliable, and low-cost testing. The goal now is to make the technology increase in signal intensity to produce less ambiguous results.

    Dec 12, 2017
  • Sarah Cannon Joins Early Breast Cancer Detection Study

    Diagnostics World Brief | Sarah Cannon announced that several of its affiliated programs will participate in a new study, called STRIVE, which focuses on developing a test for early breast cancer detection.

    Dec 8, 2017
  • AI Forerunner IDx Explains How New Test Could Cut Healthcare Costs Improve Diagnosis of Eye Disease

    Healthegy | The power of Artificial Intelligence and Machine Learning looms over Medtech as a growing force that will bring change, good or bad. In this Medtech Talk Podcast, Michael Abramoff, MD, PhD, president, director and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer.

    Dec 7, 2017
  • Quanterix Files Proposed Terms For $50 Million IPO

    Seeking Alpha | Quanterix has proposed terms for its $50 million U.S. IPO. The company plans to sell 3.34 million shares of common stock at $15.00 per share.

    Dec 6, 2017
  • Teladoc, Celmatix, ANGLE, And More: News From November 2017

    Diagnostics World | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Teladoc, Celmatix, ANGLE, and more.

    Dec 5, 2017
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67 (current)
  • 68
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy